
A Neurologist Answers Questions Patients Might Have about the New Alzheimer’s Drug Lecanemab
What a patient and family members can expect from the recently approved drug lecanemab—and what more is needed to help stop Alzheimer’s dementia
What a patient and family members can expect from the recently approved drug lecanemab—and what more is needed to help stop Alzheimer’s dementia
Stuttering is a complex neurodevelopmental condition, and learning about its causes will hopefully reduce the stigma surrounding it
There are different ways to be happy and function well, even if your brain is not typical
The brain of a new father goes through transitions analogous to the neural changes experienced by a pregnant woman
A standard diagnostic test may be one reason autism research includes so few female participants
Study in cells and mice suggests that the variant APOE4 affects the all-important insulation around nerve cells
Following a stroke, the brain’s own repair processes can lead to a strong recovery in people such as Senate candidate John Fetterman
This Scottish woman’s hypersensitive nose picked up a chemical signature of Parkinson’s disease that has been used to develop a skin-swab diagnostic
Researchers are cautiously optimistic following companies’ announcement of positive results for lecanemab
Older prisoners will make up a third of the prison population in a decade, and many of them will develop dementia
Topology, sometimes called rubber sheet geometry, is finding patterns in the brain, drugs and evolution
Multiple strategies—including speech therapy—can help those whose voice and gender identity are not aligned and can improve their quality of life
A combination of biological and social factors most likely explain the strong connection
A glitch in speech initiation gives rise to the repetition that characterizes stuttering.
A new system that targets specific spinal nerves restored motor function quickly in three patients unable to move their legs or trunk
The research could mark a turning point in the fight against MS
Hopes are high for a class of drug that could treat neurodegenerative conditions—but a recent clinical trial has brought the field up short
In search of answers, a neurobiologist looks to rodents
SARS-CoV-2 appears to travel widely across the cerebral cortex
A pushback has arisen to seasonal clock changes that affect mood, sleep and general well-being
Support science journalism.
Thanks for reading Scientific American. Knowledge awaits.
Already a subscriber? Sign in.
Thanks for reading Scientific American. Create your free account or Sign in to continue.
Create Account